Dkk3-flox Mouse
Common Name
Dkk3-flox
제품 ID
S-CKO-11394
Backgroud
C57BL/6NCya
품종 계통계통 ID
CKOCMP-50781-Dkk3-B6N-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Dkk3-flox Mouse (카탈로그 번호 S-CKO-11394)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Dkk3-flox
품종 계통계통 ID
CKOCMP-50781-Dkk3-B6N-VA
유전자명
제품 ID
S-CKO-11394
유전자 별칭
dkk-3, mDkk-3
배경
C57BL/6NCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 7
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000033036
NCBI 전사체 ID
NM_015814
타겟 영역
Exon 5~6
유효 영역 크기
~1.8 kb
유전자 연구 개요
Dkk3, belonging to the DKK family, codes for an evolutionally conserved secreted glycoprotein. It functions as an antagonist of the oncogenic Wnt signaling pathway and has been implicated in multiple biological processes and diseases [3,6,7]. Genetic models like KO/CKO mouse models are valuable for studying its functions.
In muscle-related studies, myofiber-specific ablation of Baf60c in mice led to a robust upregulation of Dkk3, which inhibited muscle stem cell differentiation and attenuated muscle regeneration in vivo. Conversely, Dkk3 blockade promoted muscle regeneration and contraction, indicating Dkk3's role in muscle regeneration through paracrine signaling [1].
In renal fibrosis, knockdown of Dkk3 in UUO mice inhibited oxidative stress, maintained mitochondrial homeostasis, and alleviated kidney damage and fibrosis. Mechanistically, Dkk3 activated the Wnt/β -catenin pathway to increase MFF transcriptional expression, leading to mitochondrial dysfunction [2].
In head and neck squamous cell carcinoma (HNSCC), Dkk3 knockdown significantly decreased cell proliferation, migration, and invasion through decreased AKT phosphorylation, suggesting its oncogenic function in HNSCC [3].
In neuropathic pain, exogenous intrathecal administration of rDKK3 inhibited microglial activation-related signaling, promoted microglia transformation from M1 to M2 type, and decreased pro-inflammatory cytokines, ameliorating neuropathic pain [4].
In chronic obstructive pulmonary disease (COPD)-related sarcopenia, Dkk3 was overexpressed, and its inhibition prevented cigarette-smoking-induced skeletal muscle dysfunction, suggesting it as a potential diagnostic and therapeutic target [5].
In children with chronic kidney disease, urinary DKK3 above the median was associated with a greater 6-month eGFR decline, and it could help identify those who benefit from pharmacological nephroprotection [8].
In conclusion, Dkk3 plays diverse roles in multiple biological processes and disease conditions. Mouse models with Dkk3 knockout or knockdown have revealed its functions in muscle regeneration, renal fibrosis, cancer, neuropathic pain, sarcopenia in COPD, and kidney function decline in children. These findings contribute to understanding disease mechanisms and potentially developing new therapeutic strategies.
References:
1. Xu, Jingya, Li, Xiaofei, Chen, Wei, Shan, Pengfei, Meng, Zhuo-Xian. 2023. Myofiber Baf60c controls muscle regeneration by modulating Dkk3-mediated paracrine signaling. In The Journal of experimental medicine, 220, . doi:10.1084/jem.20221123. https://pubmed.ncbi.nlm.nih.gov/37284884/
2. Song, Jianling, Chen, Yanxia, Chen, Yan, Ke, Ben, Fang, Xiangdong. 2024. DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway-dependent manner. In Renal failure, 46, 2343817. doi:10.1080/0886022X.2024.2343817. https://pubmed.ncbi.nlm.nih.gov/38682264/
3. Katase, Naoki, Nagano, Kenichi, Fujita, Shuichi. 2020. DKK3 expression and function in head and neck squamous cell carcinoma and other cancers. In Journal of oral biosciences, 62, 9-15. doi:10.1016/j.job.2020.01.008. https://pubmed.ncbi.nlm.nih.gov/32032750/
4. Zhang, Long-Qing, Gao, Shao-Jie, Sun, Jia, Zhou, Ya-Qun, Mei, Wei. 2022. DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation. In Journal of neuroinflammation, 19, 129. doi:10.1186/s12974-022-02495-x. https://pubmed.ncbi.nlm.nih.gov/35658977/
5. Wang, Zilin, Deng, Mingming, Xu, Weidong, Zhou, Xiaoming, Hou, Gang. 2024. DKK3 as a diagnostic marker and potential therapeutic target for sarcopenia in chronic obstructive pulmonary disease. In Redox biology, 78, 103434. doi:10.1016/j.redox.2024.103434. https://pubmed.ncbi.nlm.nih.gov/39571512/
6. Hamzehzadeh, Leila, Caraglia, Michele, Atkin, Stephen L, Sahebkar, Amirhossein. 2018. Dickkopf homolog 3 (DKK3): A candidate for detection and treatment of cancers? In Journal of cellular physiology, 233, 4595-4605. doi:10.1002/jcp.26313. https://pubmed.ncbi.nlm.nih.gov/29206297/
7. Xia, Zhiliang, Du, Dan, Zhang, Zhi, Guo, Xiong, He, Ziqiu. 2024. WIF1 and DKK3 in prostate cancer: from molecular pathways to therapeutic targets: a narrative review. In Translational andrology and urology, 13, 2601-2616. doi:10.21037/tau-24-304. https://pubmed.ncbi.nlm.nih.gov/39698576/
8. Speer, Thimoteus, Schunk, Stefan J, Sarakpi, Tamim, Fliser, Danilo, Schaefer, Franz. 2023. Urinary DKK3 as a biomarker for short-term kidney function decline in children with chronic kidney disease: an observational cohort study. In The Lancet. Child & adolescent health, 7, 405-414. doi:10.1016/S2352-4642(23)00049-4. https://pubmed.ncbi.nlm.nih.gov/37119829/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
